Sequencing therapies in oncogene-driven non-small-cell lung cancer: how to get the best mileage?

被引：1
|
作者：
Sukrithan, Vineeth [1 ]
Snyder, Rose [2 ]
Cheng, Haiying [1 ]
Halmos, Balazs [1 ]
机构：
[1] Albert Einstein Coll Med, Monteflore Med Ctr, Dept Hematol Oncol, 111 E 20th St, Bronx, NY 10467 USA
[2] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Internal Med, 1400 Pelham Pkwy South Bldg 1,Room 3N21, Bronx, NY 10461 USA
来源：
FUTURE ONCOLOGY | 2019年 / 15卷 / 25期
关键词：
ACQUIRED-RESISTANCE; PATIENT; INHIBITORS;
D O I：
10.2217/fon-2019-0103
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2899 / 2904
页数：6
相关论文
共 50 条
  • [21] The use of radiation therapy for oligoprogressive/oligopersistent oncogene-driven non small cell lung cancer: State of the art
    Franceschini, D.
    De Rose, F.
    Cozzi, S.
    Franzese, C.
    Rossi, S.
    Finocchiaro, G.
    Toschi, L.
    Santoro, A.
    Scorsetti, M.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 148
  • [22] Emerging therapies in non-small-cell lung cancer
    Khuri, FR
    Herbst, RS
    Fossella, FV
    [J]. ANNALS OF ONCOLOGY, 2001, 12 (06) : 739 - 744
  • [23] Beyond epidermal growth factor receptor: MET amplification as a general resistance driver to targeted therapy in oncogene-driven non-small-cell lung cancer
    Coleman, N.
    Hong, L.
    Zhang, J.
    Heymach, J.
    Hong, D.
    Le, X.
    [J]. ESMO OPEN, 2021, 6 (06)
  • [24] Extending the Duration of Efficacy of Targeted Therapies with Radiation to Oligoprogressive Disease (OPD) in Oncogene-Driven Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Holt, D. E.
    Patil, T.
    Camidge, D. R.
    Doebele, R.
    Kavanagh, B. D.
    Bunn, P.
    Pacheco, J. M.
    Purcell, W. T.
    Rusthoven, C. G., Jr.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S149 - S149
  • [25] Surveillance brain imaging in oncogene-driven non-small cell lung cancer: The Kent Oncology Centre experience
    Tippu, Zayd
    Shah, Riyaz
    [J]. LUNG CANCER, 2021, 156 : S21 - S22
  • [26] State of the Art: onkogen alteriertes nichtkleinzelliges Lungenkarzinom im Stadium IVState of the art: oncogene-driven stage IV non-small-cell lung cancer
    Sophie Heinzen
    Henning Reis
    Martin Sebastian
    Melanie Demes
    Jan Stratmann
    [J]. Die Onkologie, 2022, 28 (12) : 1087 - 1094
  • [27] The GATA2 Transcriptional Network is Requisite for Ras Oncogene-driven Non-small Cell Lung Cancer
    Kumar, M. S.
    Downward, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S121 - S121
  • [28] The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
    Kumar, Madhu S.
    Hancock, David C.
    Molina-Arcas, Miriam
    Steckel, Michael
    East, Phillip
    Diefenbacher, Markus
    Armenteros-Monterroso, Elena
    Lassailly, Francois
    Matthews, Nik
    Nye, Emma
    Stamp, Gordon
    Behrens, Axel
    Downward, Julian
    [J]. CELL, 2012, 149 (03) : 642 - 655
  • [29] High prevalence of pathogenic germline variants in patients with oncogene-driven non-small cell lung cancer.
    Mezquita, Laura
    Iurchenko, Andrei
    Benitez, Jose Carlos
    Baz, Maria
    Nikolaev, Sergey
    Planchard, David
    Blanc-Durand, Felix
    Aldea, Mihaela
    Martin-Romano, Patricia
    Loriot, Yohann
    Nicotra, Claudio
    Ngocamus, Maud
    Scoazec, Jean-Yves
    Michiels, Stefan
    Postel-Vinay, Sophie
    Viot, Julien
    Friboulet, Luc
    Italiano, Antoine
    Andre, Fabrice
    Massard, Christophe
    Soria, Jean-Charles
    Rouleau, Etienne
    Gautheret, Daniel
    Besse, Benjamin
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [30] Inhibition of TWIST1 Leads to Activation of Oncogene-Induced Senescence in Oncogene-Driven Non-Small Cell Lung Cancer
    Burns, Timothy F.
    Dobromilskaya, Irina
    Murphy, Sara C.
    Gajula, Rajendra P.
    Thiyagarajan, Saravanan
    Chatley, Sarah N. H.
    Aziz, Khaled
    Cho, Yoon-Jae
    Tran, Phuoc T.
    Rudin, Charles M.
    [J]. MOLECULAR CANCER RESEARCH, 2013, 11 (04) : 329 - 338
12345